Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Suzie Seabroke"'
Publikováno v:
PLoS ONE, Vol 8, Iss 2 (2013)
Externí odkaz:
https://doaj.org/article/5489a9daffbf4b1f861bb5855b23ee3d
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28157 (2011)
To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events and mortality in patients using diabetes medication.The General Practice Research Database was used to identify inception cohorts of insulin and differ
Externí odkaz:
https://doaj.org/article/d83562e0aff34519b088d6cea0f4dbe1
Autor:
Suzie Seabroke, Jenny Wong, Elizabeth Webb, Philip Bryan, Ian M. Feavers, Caroline Vipond, Charlotte Goldsmith, Katherine Donegan
Publikováno v:
The Lancet Child & Adolescent Health. 2:395-403
Safety data for the multicomponent meningococcal group B vaccine (4CMenB) has so far been limited to experience from clinical trials and isolated local outbreaks. Since the UK is the first country to implement a nationwide routine immunisation progra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19111d646af64e07dcd847e88cb68dd
https://doi.org/10.1016/s2352-4642(18)30103-2
https://doi.org/10.1016/s2352-4642(18)30103-2
Autor:
Phil Tregunno, Gianmario Candore, Kristina Juhlin, Harry Southworth, Suzie Seabroke, Miguel A. Macia-Martinez, Bharat Thakrar, G. Niklas Norén, Naashika Quarcoo, Katrin Manlik, Andreas Brueckner, Jim Slattery, Cédric Bousquet, Lionel Van Holle, Michael Kayser, Andrew Bate, Antoni Wisniewski
Publikováno v:
Drug Safety
Over a period of 5 years, the Innovative Medicines Initiative PROTECT (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) project has addressed key research questions relevant to the science of safety signal detect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c118c42f30303496b163ff53bf658bb
http://europepmc.org/articles/PMC4871909
http://europepmc.org/articles/PMC4871909
Autor:
Ramin B. Arani, Antoni Wisniewski, Jim Slattery, G. Niklas Norén, Naashika Quarcoo, Suzie Seabroke, Kristina Juhlin, Gianmario Candore, Jeffery L. Painter, Philip Michael Tregunno
Publikováno v:
Drug Safety. 39:355-364
Disproportionality analyses are used in many organisations to identify adverse drug reactions (ADRs) from spontaneous report data. Reporting patterns vary over time, with patient demographics, and between different geographical regions, and therefore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a4c2980a107ace8fbd8f020b6e446b
https://doi.org/10.1007/s40264-015-0388-3
https://doi.org/10.1007/s40264-015-0388-3
Publikováno v:
Drug Safety. 36:1025-1032
The prioritisation of drug safety issues for further evaluation or regulatory action is critical to ensure that acceptable timelines and appropriate resource allocation are defined to meet public health and regulatory obligations. Our objective was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438cf8eadb7317b15c7dddf5d545a5a4
https://doi.org/10.1007/s40264-013-0081-3
https://doi.org/10.1007/s40264-013-0081-3
Comparison of statistical signal detection methods within and across spontaneous reporting databases
Autor:
Suzie Seabroke, Naashika Quarcoo, Kristina Juhlin, Bharat Thakrar, Antoni Wisniewski, Katrin Manlik, Jim Slattery, Gianmario Candore
Publikováno v:
Drug safety. 38(6)
Most pharmacovigilance departments maintain a system to identify adverse drug reactions (ADRs) through analysis of spontaneous reports. The signal detection algorithms (SDAs) and the nature of the reporting databases vary between operators and it is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45f78873a3f2efdeb743fad2f7d2c4f6
https://pubmed.ncbi.nlm.nih.gov/25899605
https://pubmed.ncbi.nlm.nih.gov/25899605
Autor:
Katherine Donegan, Bridget King, Suzie Seabroke, Andrew Thomson, Philip Bryan, Raphaelle Beau-Lejdstrom
Publikováno v:
Vaccine. 31(43)
Introduction Over 70% of cervical cancers are related to human papillomavirus types 16 and 18. In 2008, the vaccine Cervarix, protecting against these two strains, was introduced into the routine UK immunisation programme for girls aged 12–13 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e33b52f60227684becfe32f10808d7
https://pubmed.ncbi.nlm.nih.gov/24001935
https://pubmed.ncbi.nlm.nih.gov/24001935
Publikováno v:
Vaccine. 29(51)
The monovalent H1N1 (2009) pandemic influenza vaccine used predominantly in the UK in 2009/10 was a split virion vaccine with a novel oil-in-water adjuvant (ASO3). While this was highly immunogenic it was also reactogenic especially for fever in chil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713b086abd1545d9bb0739a902ffc59c
https://pubmed.ncbi.nlm.nih.gov/22019757
https://pubmed.ncbi.nlm.nih.gov/22019757
Publikováno v:
Lancet (London, England). 376(9739)
Even in good production years, during the hunger gap (ie, the period between the point when the food stores from the last harvest run out and the new harvest is collected—usually June or July to November) tens of thousands of children have severe a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c30b98178423e68cc4397931aeb8cd
https://pubmed.ncbi.nlm.nih.gov/19880171
https://pubmed.ncbi.nlm.nih.gov/19880171